197 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
website and social media outlets to publish important information about the Company, including information that may be deemed material to investors
8-K
EX-99.1
j1trka
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
EX-99.1
x0u3ixn
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T/A
l7pp3
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T/A
xxud3t3
12 Sep 23
Third party tender offer statement (amended)
4:38pm
SC TO-T/A
i94343ynzpeoabdd
8 Sep 23
Third party tender offer statement (amended)
4:05pm
SC TO-T
EX-99
ldtcjvueacnipy1633g
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
xap94fjke
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
hbhcrlhuef
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
nb85ol el
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
j5iohve
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
PX14A6G
51x vsg2wvm97r
18 May 23
Letter to shareholders
4:46pm